Literature DB >> 35672242

Self-reactive, innate-like T cells enhance cytotoxicity and immunosurveillance.

Blaire E Barton1, Cindy H Chau1, William D Figg2.   

Abstract

Checkpoint blockade and adoptive T cell therapy are efficacious in some patients, but many do not respond to these immunotherapies. Chou et al. recently elucidated the characteristics of a new cell population with greater cytotoxicity, improved tumor homing, and reduced exhaustion compared to conventional cytotoxic T cells. These cells may improve the efficacy of cancer immunotherapies, especially for patients refractory or unresponsive to current approaches. Published by Elsevier Inc.

Entities:  

Keywords:  T cell exhaustion; immunosurveillance; immunotherapy; innate-like cytotoxic T cells; tumor homing

Mesh：

Year:  2022        PMID： 35672242      PMCID： PMC9308744          DOI： 10.1016/j.trecan.2022.05.003

Source DB:  PubMed          Journal:  Trends Cancer        ISSN： 2405-8025


  10 in total

Review 1.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

Review 2.  Human T Cell Development, Localization, and Function throughout Life.

Authors:  Brahma V Kumar; Thomas J Connors; Donna L Farber
Journal:  Immunity       Date:  2018-02-20       Impact factor: 31.745

Review 3.  The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response.

Authors:  Danilo Pagliari; Rossella Cianci; Simona Frosali; Raffaele Landolfi; Giovanni Cammarota; Estelle E Newton; Franco Pandolfi
Journal:  Cytokine Growth Factor Rev       Date:  2013-06-21       Impact factor: 7.638

4.  Programme of self-reactive innate-like T cell-mediated cancer immunity.

Authors:  Chun Chou; Xian Zhang; Chirag Krishna; Briana G Nixon; Saida Dadi; Kristelle J Capistrano; Emily R Kansler; Miranda Steele; Jian Han; Amy Shyu; Jing Zhang; Efstathios G Stamatiades; Ming Liu; Shun Li; Mytrang H Do; Chaucie Edwards; Davina S Kang; Chin-Tung Chen; Iris H Wei; Emmanouil P Pappou; Martin R Weiser; J Garcia-Aguilar; J Joshua Smith; Christina S Leslie; Ming O Li
Journal:  Nature       Date:  2022-04-20       Impact factor: 69.504

5.  Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells.

Authors:  Saïda Dadi; Sagar Chhangawala; Benjamin M Whitlock; Ruth A Franklin; Chong T Luo; Soyoung A Oh; Ahmed Toure; Yuri Pritykin; Morgan Huse; Christina S Leslie; Ming O Li
Journal:  Cell       Date:  2016-01-21       Impact factor: 41.582

6.  Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond.

Authors:  Luoyan Ai; Antao Xu; Jie Xu
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 7.  CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential.

Authors:  Vanaja Konduri; Damilola Oyewole-Said; Jonathan Vazquez-Perez; Scott A Weldon; Matthew M Halpert; Jonathan M Levitt; William K Decker
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

Review 8.  A guide to cancer immunotherapy: from T cell basic science to clinical practice.

Authors:  Alex D Waldman; Jill M Fritz; Michael J Lenardo
Journal:  Nat Rev Immunol       Date:  2020-05-20       Impact factor: 53.106

Review 9.  Neoantigen: A New Breakthrough in Tumor Immunotherapy.

Authors:  Zheying Zhang; Manman Lu; Yu Qin; Wuji Gao; Li Tao; Wei Su; Jiateng Zhong
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

Review 10.  Cytotoxic CD8+ T cells in cancer and cancer immunotherapy.

Authors:  Hans Raskov; Adile Orhan; Jan Pravsgaard Christensen; Ismail Gögenur
Journal:  Br J Cancer       Date:  2020-09-15       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.